EAM Investors’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-261,649
Closed -$3.79M 346
2024
Q3
$3.79M Buy
+261,649
New +$3.79M 0.57% 92
2023
Q2
Sell
-62,798
Closed -$409K 359
2023
Q1
$409K Sell
62,798
-61,975
-50% -$403K 0.08% 242
2022
Q4
$1.06M Buy
+124,773
New +$1.06M 0.22% 217